Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




New Blood Test to Measure Omega-3 Fatty Acids Could Help Evaluate Cardiovascular Risks

By LabMedica International staff writers
Posted on 13 Oct 2023

The human body can produce many of the fats it requires, but omega-3 fatty acids must come from our diet. More...

These essential fatty acids, specifically EPA and DHA, are mainly found in sources like fish, seafood, and certain enriched foods and supplements. A deficiency in these fatty acids can increase cardiovascular risks and is linked to issues like inflammation, mental decline, depression, and problems in fetal brain development and premature births. Currently, assessing omega-3 levels in the blood is challenging and involves an invasive blood test. Now, researchers have come up with a more convenient method to monitor these crucial fatty acids in the blood, making it easier to collect vital health data related to cardiovascular and cognitive health.

Researchers at McMaster University (Hamilton, ON, Canada) have identified a new biomarker for the Omega-3 Index (O3I) which makes it simpler to study the role of omega-3 fatty acid nutrition for overall public health, including among at-risk populations. Traditional methods for assessing O3I have involved drawing significant amounts of blood and complex lab procedures, making it an uncommon practice among healthcare providers. This new technique could enable regular screening, assisting both doctors and patients in determining the appropriate level of supplementation.

Generally, an O3I lower than 4% signifies a greater risk for cardiovascular issues, while an O3I above 8% suggests a lower risk. Importantly, the O3I can be modified through dietary changes. In the study, subjects were administered between 3 to 5 grams of fish oil, EPA, or DHA supplements daily. The research team conducted lipid profiling to pinpoint specific O3I biomarkers from the hundreds of lipids that can be found in the blood. The researchers are also working on identifying a substitute biomarker for the O3I through a urine test, which would eliminate the need for blood draws altogether.

“Our test can be part of a routine blood test without any special requirements,” says lead author Philip Britz-McKibbin, a professor of chemistry and chemical biology at McMaster. “By directly measuring only two specific biomarkers in a blood sample, we can rapidly assess the Omega-3 Index without time-consuming and costly sample workup protocols prior to analysis.”

Related Links:
McMaster University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.